The trademark application ScheBo SARS-CoV-2 was filed by ScheBo Biotech AG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on July 16, 2020, and it was registered by office on October 26, 2020 without any oppositions.
The application was filed in German (English was selected as the second language).